Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade
Abstract Immune checkpoint blockade (ICB) has significantly advanced tumor therapy, yet its overall response rates remain limited and are often accompanied by immune-related adverse effects. Immunogenic cell death (ICD), a specialized form of regulated cell death, elicits antitumor immunity through...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2026-04-01
|
| Colección: | Molecular Cancer |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s12943-026-02663-0 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|